Autopsy report · NCT00699842
A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients
Cause of deathRegulatory or ethics
“Administratively terminated per FDA recommendation”
Life of this trial
- Registered 1 month before it started.
- Ran for about 3 years 10 months before it stopped.
- 8 participants enrolled.
- Results were posted on the registry 2 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Sponsor type
- University, hospital or other
- Conditions
- Myelodysplastic Syndrome; MDS; Low to Intermediate-1 MDS; Non-deletion 5q
- Interventions
- Lenalidomide
- Participants
- 8
- Sites
- 2
- Countries
- United States
Trials that died the same way
- Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice
“Terminated after FDA agreement.” - Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography
“FDA agreed to early termination due to difficulties enrolling patients.” - A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma
“The study was terminated due to regulatory approval of newer therapeutic options and slower than anticipated accrual.” - Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
“Terminated due to unacceptable toxicity” - GSK2983559 First Time in Human Study
“Terminated due to non clinical toxicology findings and reduced safety margins.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.